Abstract
Whole body energy status is monitored by specialized hypothalamic neurons using a signaling system that responds to peripheral inputs, notably blood glucose, circulating hormone levels, and afferent neuronal signals. Recent evidence indicates that these inputs converge on a 5′-AMP kinase/malonyl-CoA signaling pathway, which regulates feeding behavior and energy expenditure. Malonyl-CoA is a metabolic intermediate in the pathway of fatty acid synthesis that responds to changes in energy status. Formation of malonyl-CoA is catalyzed by acetyl-CoA carboxylase (ACC) – a highly regulated enzyme expressed both in lipogenic tissues, muscle, and hypothalamic feeding centers. Only recently has the importance of malonyl-CoA been recognized as a signaling intermediate in the central nervous system. Hypothalamic malonyl-CoA level has been implicated in the regulation of feeding behavior. Hence, the administration (systemically or centrally) of inhibitors of fatty acid synthase (FAS) – the enzyme that succeeds ACC in the fatty acid synthetic pathway – increases hypothalamic malonyl-CoA and suppresses food intake. Lowering malonyl-CoA with an ACC inhibitor or ectopic expression of malonyl-CoA decarboxylase in the hypothalamus increases food intake and reverses blockade by FAS inhibitors. ACC is targeted by 5′-AMP kinase, phosphorylation provoking inhibition and leading to a lower malonyl-CoA level. Physiologically, hypothalamic malonyl-CoA is subject to regulation by fasting and refeeding and conditions that alter blood glucose level. As the level of glucose entering the hypothalamus increases, food intake is suppressed, and as glucose level falls, food intake is restored. The central metabolism of glucose is linked to the 5′-AMP kinase signaling system through changes in the [AMP]/[ATP] ratio. Thus, glucose metabolism provokes a rise in [ATP] which produces compensatory decreases in [AMP] level and 5′-AMP kinase activity, dephosphorylation of ACC, increased ACC activity and its reaction product, malonyl-CoA. The “malonyl-CoA signal” is relayed to the orexigenic/anorexigenic neuropeptide systems that determine hunger and energy expenditure. In contrast to centrally administered glucose, which produces satiety, centrally administered fructose has an inverse effect on feeding behavior having reciprocal effects on the intermediaries in the 5′-AMP kinase/malonyl-CoA signaling pathway. Elevated hypothalamic malonyl-CoA also rapidly triggers energy expenditure via the sympathetic nervous system connection to skeletal muscle. This gives rise to increased expression of fatty acid-oxidizing enzymes and regulators and a delayed, but significant increase in mtovhondrial biogenesis and number.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CNS:
-
Central nervous system
- SNS:
-
Sympathetic nervous system
- ACC:
-
Acetyl-CoA carboxylase
- MCD:
-
Malonyl-CoA decarboxylase
- FAS:
-
Fatty acid synthase
- icv:
-
Intracerebroventricular
- ip:
-
Intraperitoneal
- AICAR:
-
5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside
- NPY:
-
Neuropeptide Y
- AgRP:
-
Agouti-related peptide
- POMC:
-
Propiomelanocortin
- CART:
-
Cocaine and amphetamine-regulated transcript
References
Cahill GF Jr. N Engl J Med. 1970;282:668–75.
Cahill GF Jr. Diabetes. 1971;20:785–99.
Cha SH, Hu Z, Chohnan S, Lane MD. Proc Natl Acad Sci USA. 2005;102(14):557–62.
Cha SH, Hu Z, Lane MD. Biochem Biophys Res Commun. 2004;317:301–8.
Cha SH, Rodgers JT, Puigserver P, Chohnan S, Lane MD. Proc Natl Acad Sci USA. 2006;103:15410–5.
Cha SH, Wolfgang M, Tokutake Y, Chohnan S, Lane MD. Proc Natl Acad Sci USA. 2008;105:16871–5.
Chakravarthy MV, Zhu Y, Lopez M, Yin L, Wozniak DF, Coleman T, Hu Z, Wolfgang M, Vidal-Puig A, Lane MD Semenkovich CF. J Clin Invest. 2007;117:2539–52.
Gao S, Kinzig KP, Aja S, Scott KA, Keung W, Kelly S, Strynadka K, Chohnan S, Smith WW, Tamashiro K, Ladenheim EE, Ronnett GV, Tu Y, Birnbaum MJ, Lopaschuk GD, Moran TH. Proc Natl Acad Sci USA. 2007;104: 17358–63.
Gao S, Lane MD. Proc Natl Acad Sci USA. 2003;100:5628–33.
Hardie DG. Prog Lipid Res. 1989;28:117–46.
He W, Lam TK, Obici S, Rosetti L. Nat Neurosci. 2006;9:227–33.
Hu Z, Cha SH, Chohnan S, Lane MD. Proc Natl Acad Sci USA. 2003;100:12624–9.
Hu Z, Dai Y, Prentki M, Chohnan S, Lane MD. J Biol Chem. 2005;280:39681–3.
Kahn BB, Alquier T, Carling D, Hardie DG. Cell Metab. 2005;1:15–25.
Kumar MV, Shimokawa T, Nagy TR, Lane MD. Proc Natl Acad Sci USA. 2002;99:1921–5.
Lane MD. Encyclopedia of life aciences. John Wiley & Sons, Ltd. 2008. www.els.net doi: 10.1002/9780470015902.a0021317.
Lane MD, Cha SH. Biochem Biophys Res Commun. 2009;382:1–5.
Lane MD, HU Z., Cha SH, Dai Wofgang M, Sidhaya A. Biochem Soc Trans 2005;33:1063–7.
Lane MD., Watkins PA, Meredith MJ. Critical Rev Biochem. 1979;7:19–40.
Loftus TM., Jaworsky DE, Freyhywot GL, Townsend CA, Ronnett GV, Lane MD, Kuhajda FP. Science. 2000;288:2379–80.
McGarry JD. Biochem Soc Trans. 2001;29:241–5.
McGarry JD, Foster DW. J Biol Chem. 1979;254:8163–8.
McGarry JD, Leatherman GF, Foster DW. J Biol Chem. 1978;253:4128–36.
Miller CC, Martin RJ, Whitney ML, Edwards GL. Nutr Neurosci. 2002;5:359–62.
Minokoshi Y, Alquier T, Furakawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB. Nature. 2004;428:569–74.
Minokoshi Y, Kahn BB. Biochem Soc Trans. 2003;31:196–201.
Minokoshi Y, Kim YB, Peroni OD, Fryer L, Muller C, Carling D, Kahn BB. Nature. 2002;415:339–43.
Mistry AM, Helferich W, Romsos DR. Brain Res. 1994;666:53–60.
Schwartz MW, Porte D Jr. Science. 2005;307:375–9.
Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Nature. 2000;404:661–71.
Shimokawa T, Kumar MV, Lane MD. Proc Natl Acad Sci USA. 2002;99:66–71.
Thupari JN, Landree L.E, Ronnett GV, Kuhajda FP. Proc Natl Acad Sci USA. 2002;99: 498–502.
Wakil SJ, Stoops JK, Joshi VC. Annu Rev Biochem. 1983;52:537–79.
Winder WW, Hardie DG. Am J Physiol. 1999;277:E1–10.
Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutber CA, Call GB, Clayton RD, Conley LM, Yoon S, Zhou B. J Appl Physiol. 1997;82:219–25.
Wolfgang MJ, Lane MD. J Biol Chem. 2006;281:37265–9.
Wolfgang MJ, Cha SH, Sidhaya A, Chohnan S, Cline G, Shulman GI, Lane MD. Proc Natl Acad Sci USA. 2007;104:19285–90.
Wolfgang MJ, Lane MD. Mol Endocrinol 2008;22:2012–20.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Lane, M.D., Cha, S.H. (2011). Malonyl-CoA Signaling in the CNS: Hypothalamic Control of Feeding Behavior and Energy Expenditure. In: Preedy, V., Watson, R., Martin, C. (eds) Handbook of Behavior, Food and Nutrition. Springer, New York, NY. https://doi.org/10.1007/978-0-387-92271-3_39
Download citation
DOI: https://doi.org/10.1007/978-0-387-92271-3_39
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-92270-6
Online ISBN: 978-0-387-92271-3
eBook Packages: MedicineMedicine (R0)